Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28557
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDriscoll, Andrea-
dc.contributor.authorRomanuick, H-
dc.contributor.authorDinh, D-
dc.contributor.authorAmerena, J-
dc.contributor.authorBrennan, A-
dc.contributor.authorHare, David L-
dc.contributor.authorKaye, D-
dc.contributor.authorLefkovits, J-
dc.contributor.authorLockwood, S-
dc.contributor.authorNeil, C-
dc.contributor.authorPrior, D-
dc.contributor.authorReid, C-
dc.contributor.authorOrellana, L-
dc.date2021-
dc.date.accessioned2022-01-10T04:56:06Z-
dc.date.available2022-01-10T04:56:06Z-
dc.date.issued2022-03-01-
dc.identifier.citationInternational Journal of Cardiology 2022; 350: 69-76en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28557-
dc.description.abstractThis study aimed to develop a risk prediction model (AUS-HF model) for 30-day all-cause re-hospitalisation or death among patients admitted with acute heart failure (HF) to inform follow-up after hospitalisation. The model uses routinely collected measures at point of care. We analyzed pooled individual-level data from two cohort studies on acute HF patients followed for 30-days after discharge in 17 hospitals in Victoria, Australia (2014-2017). A set of 58 candidate predictors, commonly recorded in electronic medical records (EMR) including demographic, medical and social measures were considered. We used backward stepwise selection and LASSO for model development, bootstrap for internal validation, C-statistic for discrimination, and calibration slopes and plots for model calibration. The analysis included 1380 patients, 42.1% female, median age 78.7 years (interquartile range = 16.2), 60.0% experienced previous hospitalisation for HF and 333 (24.1%) were re-hospitalised or died within 30 days post-discharge. The final risk model included 10 variables (admission: eGFR, and prescription of anticoagulants and thiazide diuretics; discharge: length of stay>3 days, systolic BP, heart rate, sodium level (<135 mmol/L), >10 prescribed medications, prescription of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and anticoagulants prescription. The discrimination of the model was moderate (C-statistic = 0.684, 95%CI 0.653, 0.716; optimism estimate = 0.062) with good calibration. The AUS-HF model incorporating routinely collected point-of-care data from EMRs enables real-time risk estimation and can be easily implemented by clinicians. It can predict with moderate accuracy risk of 30-day hospitalisation or mortality and inform decisions around the intensity of follow-up after hospital discharge.en
dc.language.isoeng
dc.subjectHeart failureen
dc.subjectMortalityen
dc.subjectRe-hospitalisationen
dc.subjectRisk prediction modelen
dc.titleClinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternational Journal of Cardiologyen
dc.identifier.affiliationDeakin University, School of Nursing and Midwifery, 1 Gheringhap Street, Geelong, VIC 3220, Australia..en
dc.identifier.affiliationCardiologyen
dc.identifier.affiliationDeakin University, Biostatistics Unit, Faculty of Health, 1 Gheringhap Street, Geelong, VIC 3220, Australia..en
dc.identifier.affiliationMonash University, School of Medicine and Preventive Health, Commercial Rd, Prahran, VIC 3121, Australia..en
dc.identifier.affiliationUniversity Hospital Geelong, Cardiology Research Department, PO Box 281, Geelong 3220, Australia..en
dc.identifier.affiliationUniversity of Melbourne, School of Medicine, Swanson St, Melbourne, VIC 3001, Australia..en
dc.identifier.affiliationBaker Heart and Diabetes Institute, Commercial Rd, Prahran, VIC 3121, Australia..en
dc.identifier.affiliationAlfred Health, Department of Cardiology, Commercial Rd, Prahran, VIC 3121, Australia..en
dc.identifier.affiliationMonash Health, Department of Cardiology, 246 Clayton Rd, Clayton, VIC 3168, Australia..en
dc.identifier.affiliationWestern Health, Department of Cardiology, 160 Gordon St, Footscray, VIC 3011, Australia..en
dc.identifier.affiliationSt Vincents Hospital, Department of Cardiology, 41 Fitzroy Parade, Fitzroy, VIC 3065, Australia..en
dc.identifier.affiliationCurtin University, School of Public Health, NHMRC Centre for Research Excellence in Cardiovascular Outcomes Improvement, Kent St, Bentley, WA 6102, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/34979149/en
dc.identifier.doi10.1016/j.ijcard.2021.12.051en
dc.type.contentTexten
dc.identifier.orcid0000-0002-6837-0249en
dc.identifier.orcid0000-0001-9554-6556en
dc.identifier.pubmedid34979149
local.name.researcherDriscoll, Andrea
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptCardiology-
crisitem.author.deptCardiology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

32
checked on Nov 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.